Literature DB >> 8896491

Hepatitis B virus (HBV)/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F.

J L Casey1, G A Niro, R E Engle, A Vega, H Gomez, M McCarthy, D M Watts, K C Hyams, J L Gerin.   

Abstract

Recurring outbreaks of acute hepatitis have been a significant cause of morbidity and mortality among Peruvian military personnel stationed in the Amazon Basin region of Peru. The role of hepatitis B virus (HBV) and hepatitis D virus (HDV) infection was investigated as the possible cause of acute hepatitis among 88 military patients stationed at four different jungle outposts during 1992-1993. Analysis of serum markers indicated that 95% (84/88) had evidence of acute HBV infection; 64% (54/84) were also infected with HDV. Genetic analysis of PCR-amplified HDV and HBV fragments showed exclusively HDV genotype III and HBV genotype F. Furthermore, HDV RNA sequences were similar among patients from the same outpost but different from those at other jungle locations. The data suggested focal sources of HDV infection in the jungle environment of the outposts and, further, confirmed the unique association of HDV genotype III with severe cases of human disease in northern South America.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8896491     DOI: 10.1093/infdis/174.5.920

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  42 in total

1.  Roles of carboxyl-terminal and farnesylated residues in the functions of the large hepatitis delta antigen.

Authors:  Brendan O'Malley; David W Lazinski
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  HCV and TTV co-infection in Turin, Italy.

Authors:  Rinaldo Pellicano; Antonella Olivero; Maria Lorena Abate; Antonina Smedile; Mario Rizzetto
Journal:  Dig Dis Sci       Date:  2008-08-21       Impact factor: 3.199

Review 3.  Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.

Authors:  Nicole D Ferrante; Vincent Lo Re
Journal:  Curr HIV/AIDS Rep       Date:  2020-08       Impact factor: 5.071

4.  A prenylation inhibitor prevents production of infectious hepatitis delta virus particles.

Authors:  Bruno B Bordier; Patricia L Marion; Kazuo Ohashi; Mark A Kay; Harry B Greenberg; John L Casey; Jeffrey S Glenn
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 5.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

Review 6.  Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead.

Authors:  Heiner Wedemeyer; Michael P Manns
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-01       Impact factor: 46.802

7.  Epidemiology and molecular characterization of hepatitis B virus infection in isolated villages in the Western Brazilian Amazon.

Authors:  Márcia da Costa Castilho; Cintia Mara Costa de Oliveira; João Bosco de Lima Gimaque; Jorge Di Tommaso Leão; Wornei Silva Miranda Braga
Journal:  Am J Trop Med Hyg       Date:  2012-08-20       Impact factor: 2.345

Review 8.  Therapy of Delta Hepatitis.

Authors:  Cihan Yurdaydin; Ramazan Idilman
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-07       Impact factor: 6.915

Review 9.  Hepatitis B virus infection in Latin America: a genomic medicine approach.

Authors:  Sonia Roman; Alexis Jose-Abrego; Nora Alma Fierro; Griselda Escobedo-Melendez; Claudia Ojeda-Granados; Erika Martinez-Lopez; Arturo Panduro
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

10.  Hepatitis D virus genotypes in intravenous drug users in taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes.

Authors:  Jia-Horng Kao; Pei-Jer Chen; Ming-Yang Lai; Ding-Shinn Chen
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.